Current understanding of Alzheimer’s disease diagnosis and treatment

Weller, Jason, Budson, Andrew·2018·F1000Research

Cited by (1,000)

Items 101–200 of 1,000

  1. Role and therapeutic implications of protein glycosylation in neuroinflammation
    Rebelo, Ana Lúcia, Chevalier, Merari Tumin, Russo, Laura, Pandit, Abhay · 2022 · Trends in Molecular Medicine
  2. Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
    Somayra S. A. Mamsa, Bruno P. Meloni · 2021 · Frontiers in Molecular Neuroscience
  3. Testosterone, cognitive decline and dementia in ageing men
    Bu Beng Yeap, Leon A Flicker · 2022 · Reviews in Endocrine and Metabolic Disorders
  4. Oral Administration of the Food-Derived Hydrophilic Antioxidant Ergothioneine Enhances Object Recognition Memory in Mice
    Noritaka Nakamichi, Shunsuke Nakao, Misa Nishiyama, Yuka Takeda, Takahiro Ishimoto, Yusuke Masuo, Satoshi Matsumoto, Makoto Suzuki, Yukio Kato · 2020 · Current Molecular Pharmacology
  5. The Mammalian Family of Katanin Microtubule-Severing Enzymes
    Nicole A. Lynn, Emily M. Martinez, Hieu Thi Nguyen, Jorge Z. Torres · 2021 · Frontiers in Cell and Developmental Biology
  6. Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress
    Zexing Wang, Wenwen Lian, Jun He, Xiao-Li He, Yuming Wang, Chenhao Pan, Mei Li, Wei‐Ku Zhang, Lian-Qi Liu, Jie‐Kun Xu · 2022 · Journal of Ethnopharmacology
  7. Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
    Lingyan Zheng, Sichen Wu, Haichao Jin, Jiaqi Wu, Xiaole Wang, Yuxiao Cao, Zhihao Zhou, Yaona Jiang, Linhong Li, Xinyue Yang et al. · 2023 · Phytomedicine
  8. Large Language Models Are Clinical Reasoners: Reasoning-Aware Diagnosis Framework with Prompt-Generated Rationales
    Taeyoon Kwon, Kai Tzu-iunn Ong, Dong-Jin Kang, Seungjun Moon, Jeong Ryong Lee, Dosik Hwang, Beomseok Sohn, Yongsik Sim, Dong Ha Lee, Jinyoung Yeo · 2024 · Proceedings of the AAAI Conference on Artificial Intelligence
  9. RETRACTED ARTICLE: Knockdown of long non-coding RNA TUG1 depresses apoptosis of hippocampal neurons in Alzheimer’s disease by elevating microRNA-15a and repressing ROCK1 expression
    Xia Li, Sheng-Wu Wang, Xiling Li, Feng-Yuan Yu, Hai‐Ming Cong · 2020 · Inflammation Research · Retracted
  10. Platycodin D Inhibits β-Amyloid-Induced Inflammation and Oxidative Stress in BV-2 Cells Via Suppressing TLR4/NF-κB Signaling Pathway and Activating Nrf2/HO-1 Signaling Pathway
    Jing Zhang, Na Song, Yuzhi Liu, Junwei Guo · 2021 · Neurochemical Research
  11. The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning
    Ángela Y. García Fonseca, Cynthia Martín-Jiménez, George Emilio Barreto, Andrés Felipe Aristizábal-Pachón, Janneth González · 2021 · Biomolecules
  12. The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model
    Juyong Kim, Pilju Choi, Young‐Tae Park, Taejung Kim, Jungyeob Ham, Jin‐Chul Kim · 2023 · International Journal of Molecular Sciences
  13. Plant isoquinoline alkaloids as potential neurodrugs: A comparative study of the effects of benzo[c]phenanthridine and berberine-based compounds on β-amyloid aggregation
    Daniela Marasco, Caterina Vicidomini, Paweł Krupa, Federica Cioffi, Pham Dinh Quoc Huy, Mai Suan Li, Daniele Florio, Kerensa Broersen, Maria Francesca De Pandis, Giovanni Nicola Roviello · 2020 · Chemico-Biological Interactions
  14. Enhancing of dataset using DeepDream, fuzzy color image enhancement and hypercolumn techniques to detection of the Alzheimer's disease stages by deep learning model
    Mesut Toğaçar, Zafer Cömert, Burhan Ergen · 2021 · Neural Computing and Applications
  15. Lipid Mass Tags via Aziridination for Probing Unsaturated Lipid Isomers and Accurate Relative Quantification**
    Tingyuan Yang, Shuli Tang, Syuan-Ting Alex Kuo, Dallas P. Freitas, Madison E. Edwards, Hongying Wang, Yuxiang Sun, Xin Yan · 2022 · Angewandte Chemie International Edition
  16. Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
    Cody L Slater, Qi Wang · 2021 · Clinical and Translational Medicine
  17. Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases
    Anna Litwiniuk, Agnieszka Baranowska-Bik, Anita Domańska, Małgorzata Kalisz, Wojciech Bik · 2021 · Pharmaceuticals
  18. Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples
    Qingqin S. Li, Diana Cai · 2021 · Frontiers in Neuroscience
  19. siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
    Muhammad Imran Sajid, Fahad Sultan Sheikh, Faiza Anis, Nourina Nasim, Rachita K. Sumbria, Surya M. Nauli, Rakesh Kumar Tiwari · 2023 · Advanced Drug Delivery Reviews
  20. A Novel Deep Learning Architecture Optimization for Multiclass Classification of Alzheimer’s Disease Level
    Mahır Kaya, Yasemin ÇETİN KAYA · 2024 · IEEE Access
  21. Global mortality, prevalence and disability-adjusted life years of Alzheimer’s disease and other dementias in adults aged 60 years or older, and the impact of the COVID-19 pandemic: a comprehensive analysis for the global burden of disease 2021
    Dorothy Yu, Rui-Xuan Li, Jing-Ran Sun, Xue-Wen Rong, Xu‐Guang Guo, Guodong Zhu · 2025 · BMC Psychiatry
  22. Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
    Jaione Auzmendi-Iriarte, Ander Matheu · 2021 · Frontiers in Aging Neuroscience
  23. Psychometric properties of the Alzheimer’s Disease Cooperative Study – Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial
    Michele H. Potashman, Menglan Pang, Muna J. Tahir, Saeid Shahraz, Sascha Dichter, Robert Perneczky, Sandra Nolte · 2023 · BMC Geriatrics
  24. Brain Disorders and Chemical Pollutants: A Gap Junction Link?
    Marc Mesnil, Norah Defamie, Christian C. G. Naus, Denis Sarrouilhe · 2020 · Biomolecules
  25. Lithium beyond psychiatric indications: the reincarnation of a new old drug
    Matteo Haupt, Mathias Bähr, Thorsten Roland Doeppner · 2021 · Neural Regeneration Research
  26. Identification of bioactive peptides from a Brazilian kefir sample, and their anti-Alzheimer potential in Drosophila melanogaster
    Serena Mares Malta, Letícia Leandro Batista, Heitor Cappato Guerra Silva, Rodrigo Rodrigues Franco, Matheus Henrique Silva, Tamíris Sabrina Rodrigues, Lucas Ian Veloso Correia, Mário Machado Martins, Gabriela Venturini, Foued Salmen Espíndola et al. · 2022 · Scientific Reports
  27. Sirtuins and cognition: implications for learning and memory in neurological disorders
    Eric A. Fagerli, Iris Escobar, Fernando J. Ferrier, Charles W. Jackson, Efrain J. Perez Lao, Miguel A. Pérez‐Pinzón · 2022 · Frontiers in Physiology
  28. Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells
    Fabian Dieter, Carsten Esselun, Gunter Peter Eckert · 2022 · International Journal of Molecular Sciences
  29. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer’s Disease, Lithium, and Autophagy
    Odeya Damri, Nofar Shemesh, Galila Agam · 2020 · International Journal of Molecular Sciences
  30. A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission
    Phuna, Zhi Xin, Madhavan, Priya · 2022 · European Journal of Neuroscience
  31. Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
    Steven G. Fagan, Sibylle Béchet, Kumlesh Kumar Dev · 2022 · Molecular Neurobiology
  32. Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond
    Lydia Sauer, Alexandra S. Vitale, Natalie K. Modersitzki, Paul S. Bernstein · 2020 · Eye
  33. In vitro examination of anti-parasitic, anti-Alzheimer, insecticidal and cytotoxic potential of Ajuga bracteosa Wallich leaves extracts
    Muhammad Imran, Hasnain Jan, Shah Faisal, Sajjad Ali Shah, Sumaira Shah, Muhammad Naeem Khan, Muhammad Taj Akbar, Muhammad Rizwan, Faheem Jan, Suliman Syed · 2021 · Saudi Journal of Biological Sciences
  34. Neuroprotective effects of quercetin produced by an endophytic fungus <i>Nigrospora oryzae</i> isolated from <i>Tinospora cordifolia</i>
    Vig, Rajat, Bhadra, Fatima, Gupta, Sukesh Kumar, Sairam, Krishnamurthy, Vasundhara, Mondem · 2022 · Journal of Applied Microbiology
  35. Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications
    Jessica N. Ziegler, Changhai Tian · 2023 · International Journal of Molecular Sciences
  36. Recent advances in functional lipid-based nanomedicines as drug carriers for organ-specific delivery
    Yeochan Yun, Jingyan An, Hyun Joong Kim, Hye Kyu Choi, Hyeon‐Yeol Cho · 2025 · Nanoscale
  37. Search for new multi-target compounds against Alzheimer’s disease among histamine H3 receptor ligands
    Marek Bajda, Dorota Łażewska, Justyna Godyń, Paula Zaręba, Kamil Kuder, Stefanie Hagenow, Kamil Łątka, Ewelina Stawarska, Holger Stark, Katarzyna Kieć‐Kononowicz et al. · 2019 · European Journal of Medicinal Chemistry
  38. Low-rank nonnegative matrix factorization on Stiefel manifold
    Ping He, Xiaohua Xu, Jie Ding, Baichuan Fan · 2019 · Information Sciences
  39. Icariin ameliorate Alzheimer’s disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis
    Yao Chen Chuang, Iat‐Kio Van, Yonghua Zhao, Youhua Xu · 2021 · Journal of Chemical Neuroanatomy
  40. The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease
    Tanzil Rujeedawa, Eva Carrillo Félez, I. C. H. Clare, Juan Fortea, André Strydom, Anne‐Sophie Rebillat, Antonia M. W. Coppus, Johannes Levin, Shahid H. Zaman · 2021 · Journal of Clinical Medicine
  41. Benign regulation of the gut microbiota: The possible mechanism through which the beneficial effects of manual acupuncture on cognitive ability and intestinal mucosal barrier function occur in APP/PS1 mice
    Xin Hao, Ning Ding, Yue Zhang, Yichen Yang, Yali Zhao, Jun Jie Zhao, Yiran Li, Zhigang Li · 2022 · Frontiers in Neuroscience
  42. Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review)
    Shahid Bashir, Mohammad Uzair, Turki Abualait, Muhammad Moin Ud Din Arshad, Roaa A. Khallaf, Asim Niaz, Ziyad Thani, Woo‐Kyoung Yoo, Isaac Túnez, Aslı Demirtaş-Tatlıdede et al. · 2022 · Molecular Medicine Reports
  43. Recent advances from metabolomics and lipidomics application in alzheimer’s disease inspiring drug discovery
    Miroslava Čuperlović‐Culf, AmanPreet Badhwar · 2019 · Expert Opinion on Drug Discovery
  44. Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer’s disease?
    Manuel Glauco Carbone, Giovanni Pagni, Claudia Tagliarini, Bruno Pietro Imbimbo, Nunzio Pomara · 2021 · Ageing Research Reviews
  45. Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs
    Georgia Dorahy, Zheng Chen, Thomas Balle · 2023 · Molecules
  46. Insight into role of triazole derived Schiff base bearing sulfonamide derivatives in targeting Alzheimer's disease: Synthesis, characterization, in vitro and in silico assessment
    Shoaib Ahmed Khan, Rafaqat Hussain, Yousaf Khan, Tayyiaba Iqbal, Muhammad Bilal Khan, Khairia Mohammed Al‐Ahmary, Saedah Rwede AL-Mhyawi · 2024 · Journal of Molecular Structure
  47. Decoding the Neuroprotective Potential of Methyl Gallate-Loaded Starch Nanoparticles against Beta Amyloid-Induced Oxidative Stress-Mediated Apoptosis: An In Vitro Study
    Prakashkumar Nallasamy, Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut, Natarajan Suganthy · 2021 · Pharmaceutics
  48. Memory related molecular signatures: The pivots for memory consolidation and Alzheimer's related memory decline
    Medha Kaushik, Pooja Kaushik, Suhel Parvez · 2022 · Ageing Research Reviews
  49. Causal Relationships Between Osteoarthritis and Senile Central Nerve System Dysfunction: A Bidirectional Two-Sample Mendelian Randomization Study
    Yuan-Qing Cai, Guang-ji Zhang, Jia-Lin Liang, Zhao Jing, Rupeng Zhang, Leifeng Lv, Xiao-Qian Dang · 2022 · Frontiers in Aging Neuroscience
  50. Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
    Maria Sofia Basile, Placido Bramanti, Emanuela Mazzon · 2022 · Molecules
  51. The effects of nitric oxide in Alzheimer’s disease
    Lingling Wang, Dengfeng Lu, Xiaodong Wang, Zongqi Wang, Wen Li, Gang Chen · 2023 · Medical Gas Research
  52. Automated detection of Alzheimer's disease using bi-directional empirical model decomposition
    Joel E.W. Koh, Jahmunah Vicnesh, The‐Hanh Pham, Shu Lih Oh, Edward J. Ciaccio, U. Rajendra Acharya, Chai Hong Yeong, Mohd Kamil Bin Mohd Fabell, Kartini Rahmat, Anushya Vijayananthan et al. · 2020 · Pattern Recognition Letters
  53. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review
    John Eugene Lewis, Jillian Poles, Delaney P Shaw, Elisa Karhu, Sher Ali Khan, Annabel E Lyons, Susana Barreiro Sacco, H. Reginald McDaniel · 2021 · Journal of Clinical and Translational Research
  54. A review of the application of three-dimensional convolutional neural networks for the diagnosis of Alzheimer’s disease using neuroimaging
    Xinze Xu, Lan Lin, Shen Sun, Shuicai Wu · 2023 · Reviews in the Neurosciences
  55. Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment Aβ 25-35
    Yiyun Ding, Hongxia Zhang, Zhaojun Liu, Qiuping Li, Yujiao Guo, Ye Chen, Yue Chang, Hongyan Cui · 2021 · Bioengineered
  56. A new generation of AD biomarkers: 2019 to 2021
    Jade I. Hawksworth, Esperanza Fernández, Kris Gevaert · 2022 · Ageing Research Reviews
  57. Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
    Behnam Iravani, Elahe Abdollahi, Fatemeh Eslamdoust-Siahestalkhi, Robabeh Soleimani · 2022 · Frontiers in Neurology
  58. Fusobacterium nucleatum infection-induced neurodegeneration and abnormal gut microbiota composition in Alzheimer’s disease-like rats
    Caixia Yan, Qilin Diao, Yuxi Zhao, Cheng Zhang, Xiaoya He, Ruijie Huang, Yan Li · 2022 · Frontiers in Neuroscience
  59. Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review
    Saikumar Aramadaka, Raam Mannam, Rajagopal Sankara Narayanan, Arpit Bansal, Vishnu R. Yanamaladoddi, Sai Suseel Sarvepalli, Shree Laya Vemula · 2023 · Cureus
  60. Tau‐targeting nanoparticles for treatment of Alzheimer's disease
    Shreya Pawar, Mohd Ahmar Rauf, Hosam Gharib Abdelhady, Arun K. Iyer · 2024 · Exploration
  61. Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system
    Qian Luo, Jiaying Yang, Mei Yang, Yingtong Wang, Yiran Liu, Ji‐Xuan Liu, Dhan V. Kalvakolanu, Xianling Cong, Jinnan Zhang, Ling Zhang et al. · 2025 · Materials Today Bio
  62. Monocytes in the Peripheral Clearance of Amyloid-β and Alzheimer’s Disease
    Huifang Guo, Zhaohua Zhao, Ruisan Zhang, Peng Chen, Xiaohua Zhang, Fan Cheng, Xingchun Gou · 2019 · Journal of Alzheimer s Disease
  63. Key Disease Mechanisms Linked to Alzheimer’s Disease in the Entorhinal Cortex
    Virginie Bottero, Dallen Powers, Ashna Yalamanchi, James P. Quinn, Judith A. Potashkin · 2021 · International Journal of Molecular Sciences
  64. Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies
    Yun Xu, Jiming Kong, Pingzhao Hu · 2021 · Frontiers in Pharmacology
  65. FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders
    Vaibhav Oli, Rohan V. Gupta, Pravir Kumar · 2021 · Journal of Chemical Neuroanatomy
  66. Necroptosis in Alzheimer’s disease: Potential therapeutic target
    Riane Richard, Shaker A. Mousa · 2022 · Biomedicine & Pharmacotherapy
  67. Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
    Bell, Andrew S., Wagner, Josephin, Rosoff, Daniel B., Lohoff, Falk W. · 2023 · Neuroscience &amp; Biobehavioral Reviews
  68. Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases
    Orkid Coskuner‐Weber, Vladimir Nikolaevich Uversky · 2019 · Progress in molecular biology and translational science
  69. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review
    David Vicente-Zurdo, Noelia Rosales‐Conrado, María Eugenia León‐González · 2023 · Talanta
  70. Sex Differences in Biological Processes and Nitrergic Signaling in Mouse Brain
    Игорь Германович Халиулин, Maryam Kartawy, Haitham Amal · 2020 · Biomedicines
  71. Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2
    Rui Wang, Jingjing Zhang · 2020 · Experimental Gerontology
  72. New Insights on the Role of N6-Methyladenosine RNA Methylation in the Physiology and Pathology of the Nervous System
    Georgia Dermentzaki, Francesco Lotti · 2020 · Frontiers in Molecular Biosciences
  73. Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non–muscle-invasive Bladder Cancer
    Joseph I. Kim, Denzel Zhu, Emily Barry, Evan Z. Kovac, Ahmed A. Aboumohamed, Ilir Agalliu, Alex Sankin · 2021 · Clinical Genitourinary Cancer
  74. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease
    Kemeng Pan, Song Chen, Yue Wang, Wenbing Yao, Xiangdong Gao · 2021 · Neuropharmacology
  75. Acetylcholine esterase inhibitory activity of green synthesized nanosilver by naphthopyrones isolated from marine-derived Aspergillus niger
    Ghada M. Abdelwahab, Amira Mira, Yuan‐Bin Cheng, Tarek A. Abdelaziz, M. Lahloub, Ashraf Taha Khalil · 2021 · PLoS ONE
  76. Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
    Rajashree Banerjee, Arushi Rai, Shreyas Iyer, Sonia Narwal, Meghana Tare · 2022 · Animal Models and Experimental Medicine
  77. Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
    Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Marta Roca, Lorena García, Miguel Baquero, Consuelo Cháfer‐Pericás · 2022 · Journal of Clinical Medicine
  78. The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
    Jack Jonathan Maran, Moradeke M. Adesina, Colin Richard Green, Andrea Kwakowsky, Odunayo Omolola Mugisho · 2023 · Ageing Research Reviews
  79. Gut-brain axis and Alzheimer's disease: Therapeutic interventions and strategies
    Hetender Singh, Chirag Chopra, Hemender Singh, Vikas Malgotra, Atif Khurshid Wani, Daljeet Singh Dhanjal, Indu Sharma, Eugenie Nepovimová, Suliman Yousef Alomar, Reena Singh et al. · 2023 · Journal of Functional Foods
  80. The relationship between hypoxia and Alzheimer’s disease: an updated review
    Borui Tao, Wei Gong, Chengyuan Xu, Zhihui Ma, Jinyu Mei, Ming Chen · 2024 · Frontiers in Aging Neuroscience
  81. Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases
    Cameron Lenahan, Rajvee Sanghavi, Lei Huang, John H. Zhang · 2020 · Frontiers in Neuroscience
  82. New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
    Micaela Riscado, Bruno Baptista, Fani Pereira de Sousa · 2021 · Pharmaceutics
  83. Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders
    Amaresh Kumar Ranjan, Anil Gulati · 2022 · International Journal of Molecular Sciences
  84. Probing neural circuit mechanisms in Alzheimer’s disease using novel technologies
    Steven F. Grieco, Todd C. Holmes, Xiangmin Xu · 2023 · Molecular Psychiatry
  85. Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
    Ernest James Phillips, Thomas, Maguire, Emily · 2021 · Frontiers in Cellular Neuroscience
  86. Alzheimer's disease: 120 years of research and progress
    V. Ciurea, Răzvan-Adrian Covache-Busuioc, Aurel George Mohan, Horia Petre Costin, Victor A. Voicu · 2023 · Journal of Medicine and Life
  87. The role of estrogen in Alzheimer’s disease pathogenesis and therapeutic potential in women
    Xinyi Wang, Shu Feng, Qianting Deng, Chongyun Wu, Rui Duan, Luodan Yang · 2024 · Molecular and Cellular Biochemistry
  88. Diagnosis of Alzheimer's Disease from Brain Magnetic Resonance Imaging Images using Deep Learning Algorithms
    R.C. Suganthe, R.S. Latha, M. Kalaiselvi Geetha, G. R. Sreekanth · 2020 · Advances in Electrical and Computer Engineering
  89. Poria cocos polysaccharide attenuates damage of nervus in Alzheimer’s disease rat model induced by D-galactose and aluminum trichloride
    Xibin Zhou, Yuxing Zhang, Yiqian Jiang, Chunxiang Zhou, Yun Ling · 2021 · Neuroreport
  90. Use of Zebrafish Genetic Models to Study Etiology of the Amyloid-Beta and Neurofibrillary Tangle Pathways in Alzheimer's Disease
    Jennifer L. Freeman, Keturah Kiper · 2021 · Current Neuropharmacology
  91. Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease
    Choy Ker Woon, Wong Kah Hui, Razif Abas, Muhammad Huzaimi Haron, Srijit Das, Teoh Seong Lin · 2021 · Current Neuropharmacology
  92. Tau protein aggregation: Key features to improve drug discovery screening
    Johanna Giovannini, Willy Smeralda, Marie Jouanne, Jana Sopková‐de Oliveira Santos, Marco Catto, Anne Sophie Voisin‐Chiret · 2022 · Drug Discovery Today
  93. Mechanistic Insight into the Inhibition of Choline Acetyltransferase by Proton Pump Inhibitors
    Anurag T. K. Baidya, Bhanuranjan Das, Bharti Devi, Bengt Långström, Hans Ågren, Taher Darreh‐Shori, Rajnish Kumar · 2023 · ACS Chemical Neuroscience
  94. Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases
    Meghraj Vivekanand Suryawanshi, Pranjal P. Gujarathi, Taufik Mulla, Imtiyaz Bagban · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  95. Implications of organophosphate pesticides on brain cells and their contribution toward progression of Alzheimer's disease
    Bharti Yadav, Sharanjot Kaur, Anuradha Yadav, Harkomal Verma, Swastitapa Kar, Binit Kumar Sahu, Kumari Riya Pati, Bibekanada Sarkar, Monisha Dhiman, Anil Kumar Mantha · 2024 · Journal of Biochemical and Molecular Toxicology
  96. Emerging Role of m6 A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment
    Godwin Sokpor, Yuanbin Xie, Huu Phuc Nguyen, Tran Tuoc · 2021 · Frontiers in Cell and Developmental Biology
  97. Therapeutic Potential of Human Stem Cell Implantation in Alzheimer’s Disease
    Hau Jun Chan, Yanshree, Jaydeep Roy, George Lim Tipoe, Man‐Lung Fung, Lee Wei Lim · 2021 · International Journal of Molecular Sciences
  98. Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
    Laura Ferré‐González, Carmen Peña‐Bautista, Miguel Baquero, Consuelo Cháfer‐Pericás · 2022 · Antioxidants
  99. Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review
    Sara Young, Enoch C. Chung, Michael A. Chen · 2021 · Annals of Geriatric Medicine and Research
  100. Advanced nano delivery system for stem cell therapy for Alzheimer's disease
    Yilong Pan, Long Li, Ning Cao, Jun Liao, Huiyue Chen, Meng Zhang · 2024 · Biomaterials